Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Catyalyst Pharmaceutical Partners, Inc. (NQ: CPRX)
0.8799 USD  +0.0449 (+5.38%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Catyalyst Pharmaceutical Partners, Inc.
 
< Previous 1 2 3 4 Next >
Catalyst Pharmaceutical Partners Reports First Quarter 2013 Financial Results
May 16, 2013
from GlobeNewswire News Releases
Catalyst Pharmaceutical Partners Inc is Featured as the Daily Stock to Watch on Smallcappower.com
April 22, 2013
from Newsfile Corp News Releases
The Market Slips Lower and eBay Falls on Earnings Outlook
April 19, 2013
from PR Newswire
Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2012 Financial Results
April 02, 2013
from GlobeNewswire News Releases
Catalyst Pharmaceutical Partners Announces Recommendation of Data Monitoring Committee for Pivotal Phase lll Clinical Trial for Firdapse(TM)
March 27, 2013
from GlobeNewswire News Releases
Catalyst Pharmaceutical Partners to Present at 25th Annual ROTH Conference
March 07, 2013
from GlobeNewswire News Releases
Catalyst Pharmaceutical Partners Appoints Dr. Bernardino Mosquera as Vice President of Clinical Operations
March 05, 2013
from GlobeNewswire News Releases
Catalyst Pharmaceutical Partners Launches New Website
February 21, 2013
from GlobeNewswire News Releases
Catalyst Pharmaceutical Partners Provides Update on Research and Development Pipeline
February 11, 2013
from GlobeNewswire News Releases
Catalyst Pharmaceutical Partners to Present at 15th Annual BIO CEO & Investor Conference
February 05, 2013
from GlobeNewswire News Releases
Catalyst Receives Guidance From NASDAQ Regarding Minimum Bid Price Requirement
December 27, 2012
from GlobeNewswire News Releases
Should Recent Insider Buying on LINTA, HMA, CLX and CPRX Matter to You?
December 17, 2012
from Marketwired News Releases
Catalyst Pharmaceutical Partners Announces Automatic Conversion of $5 Million Promissory Note Into Shares of Common Stock
December 11, 2012
from GlobeNewswire News Releases
Catalyst Pharmaceutical Partners Announces Third Quarter 2012 Financial Results
November 15, 2012
from GlobeNewswire News Releases
Improving Trend in for FDA First Cycle Review Approvals a Major Factor for Biotech Industry's Success in 2012
November 12, 2012
Five Star Equities Provides Stock Research on BioCryst Pharmaceuticals and Catalyst Pharmaceutical Read More
from Marketwired News Releases
Free Research Reports on BCRX, CPRX, ES and MWW Issued by the Bedford Report
November 09, 2012
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II(b) Trial for Cocaine Addiction
November 08, 2012
from GlobeNewswire News Releases
Catalyst Pharmaceutical Partners and BioMarin Pharmaceutical Enter Into Strategic Collaboration for Firdapse(TM) in North America
October 31, 2012
from GlobeNewswire News Releases
Catalyst Pharmaceutical Partners Updates Guidance on Timing of Top-Line Data From CPP-109 Phase II(b) Clinical Trial for the Treatment of Cocaine Addiction
September 26, 2012
Results to Still Be Reported Several Months Earlier Than Originally Expected Read More
from GlobeNewswire News Releases
Catalyst Pharmaceutical Partners Announces Commencement of CPP-109 Investigator-Sponsored Study in Patients With Treatment Refractory Tourette's Disorder
September 24, 2012
from GlobeNewswire News Releases
Faster FDA Review Process a Contributing Factor to Biotech Industry's Rise in 2012
September 20, 2012
The Paragon Report Provides Stock Research on Anthera Pharmaceuticals and Catalyst Pharmaceutical Read More
from Marketwired News Releases
Catalyst Pharmaceutical Partners to Present at Rodman & Renshaw's 14th Annual Healthcare Conference
September 06, 2012
from GlobeNewswire News Releases
Catalyst Pharmaceutical Partners, Inc. Announces Closing of Previously Announced $6 Million Registered Direct Offering
August 30, 2012
from GlobeNewswire News Releases
Catalyst Pharmaceutical Partners, Inc. Raises $6 Million in Registered Direct Offering
August 28, 2012
from GlobeNewswire News Releases
Catalyst Pharmaceutical Partners Announces Second Quarter 2012 Financial Results
August 15, 2012
from GlobeNewswire News Releases
Catalyst Pharmaceutical Partners Regains Compliance With NASDAQ Minimum Bid Price Rule
August 03, 2012
from GlobeNewswire News Releases
CGFIA, MIKP, CPRX and MHYS are the Stock(s) to Watch for July 25th from OTCPicks.com
July 25, 2012
from EmailWire.Com Press Releases
Catalyst Pharmaceutical Partners to Announce Top-Line Data From CPP-109 Phase II(b) Clinical Trial for the Treatment of Cocaine Addiction Earlier Than Expected
July 12, 2012
from GlobeNewswire News Releases
Scientific Paper Describing the Ocular Safety of Short-Term Vigabatrin Treatment for Cocaine Addiction in Online Edition of American Journal of Ophthalmology
June 28, 2012
Vigabatrin Did Not Cause Visual Acuity Decrease or Peripheral Vision Constriction Read More
from GlobeNewswire News Releases
Catalyst Receives Guidance From NASDAQ Regarding Minimum Bid Price Requirement
June 21, 2012
from GlobeNewswire News Releases
< Previous 1 2 3 4 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here